ALTO-300 in Depression (ALTO-300-004)

Status:
Not yet recruiting

Trial end date:
2022-09-01

Target enrollment:

Participant gender:

The purpose of this study is to collect biologically-based data for defining predictors and correlates of the effects of ALTO-300.

Phase 2

Alto Neuroscience